Cost of treatment of oesophageal variceal bleeding in patients with cirrhosis in France: results of a French survey

Thabut, Dominique; Hammer, Mette; Cai, Yan; Carbonell, Nicolas

doi:10.1097/meg.0b013e3281bcb784

Cited by 17 publications

(5 citation statements)

References 21 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The cost of treating an oesophageal varices bleed is assumed to be £10,000. This has been estimated from a weighted average of costs presented by Thabut et al, 161 which was €11,982; these costs are similar to figures reported in Wechowski et al 162 9. An endoscopy once every 3 years to be provided for those without varices and every 2 years for those patients with small or moderate varices.…”

Section: Incorporating Oesophageal Varices Bleedingsupporting

confidence: 71%

Non-invasive diagnostic assessment tools for the detection of liver fibrosis in patients with suspected alcohol-related liver disease: a systematic review and economic evaluation

Stevenson

Lloyd-Jones²,

Morgan³

et al. 2012

Health Technol Assess

View full text Add to dashboard Cite

An electronic version of this title, in Adobe Acrobat format, is available for downloading free of charge for personal use from the HTA website (www.hta.ac.uk). A fully searchable DVD is also available (see below).Printed copies of HTA journal series issues cost £20 each (post and packing free in the UK) to both public and private sector purchasers from our despatch agents.Non-UK purchasers will have to pay a small fee for post and packing. For European countries the cost is £2 per issue and for the rest of the world £3 per issue. How to order:-fax (with credit card details) -post (with credit card details or cheque) -phone during office hours (credit card only).Additionally the HTA website allows you to either print out your order or download a blank order form. Contact details are as follows:Synergie UK (HTA Department) Digital House, The Loddon Centre Wade Road Basingstoke Hants RG24 8QW Email: orders@hta.ac.uk Tel: 0845 812 4000 -ask for 'HTA Payment Services' (out-of-hours answer-phone service) Fax: 0845 812 4001 -put 'HTA Order' on the fax header Payment methods Paying by chequeIf you pay by cheque, the cheque must be in pounds sterling, made payable to University of Southampton and drawn on a bank with a UK address.Paying by credit card You can order using your credit card by phone, fax or post. SubscriptionsNHS libraries can subscribe free of charge. Public libraries can subscribe at a reduced cost of £100 for each volume (normally comprising 40-50 titles). The commercial subscription rate is £400 per volume (addresses within the UK) and £600 per volume (addresses outside the UK). Please see our website for details. Subscriptions can be purchased only for the current or forthcoming volume.How do I get a copy of HTA on DVD?Please use the form on the HTA website (www.hta.ac.uk/htacd/index.shtml). HTA on DVD is currently free of charge worldwide.The website also provides information about the HTA programme and lists the membership of the various committees. HTANon-invasive diagnostic assessment tools for the detection of liver fibrosis in patients with suspected alcohol-related liver disease: a systematic review and economic evaluation NIHR Health Technology Assessment programmeThe Health Technology Assessment (HTA) programme, part of the National Institute for Health Research (NIHR), was set up in 1993. It produces high-quality research information on the effectiveness, costs and broader impact of health technologies for those who use, manage and provide care in the NHS. 'Health technologies' are broadly defined as all interventions used to promote health, prevent and treat disease, and improve rehabilitation and long-term care. The research findings from the HTA programme directly influence decision-making bodies such as the National Institute for Health and Clinical Excellence (NICE) and the National Screening Committee (NSC). HTA findings also help to improve the quality of clinical practice in the NHS indirectly in that they form a key component of the 'National Knowledge Service' . The HTA programme ...

show abstract

Section: Incorporating Oesophageal Varices Bleedingsupporting

confidence: 71%

Non-invasive diagnostic assessment tools for the detection of liver fibrosis in patients with suspected alcohol-related liver disease: a systematic review and economic evaluation

Stevenson

Lloyd-Jones²,

Morgan³

et al. 2012

Health Technol Assess

View full text Add to dashboard Cite

show abstract

“…There was a significant increase in both the length of stay and cost of care over the study period. This finding is likely due to an aging population and the multiple comorbidities experienced by older patients (23).…”

Section: Discussionmentioning

confidence: 98%

Inpatient burden of esophageal varices in the United States: analysis of trends in demographics, cost of care, and outcomes

et al. 2019

View full text Add to dashboard Cite

Background: Esophageal variceal bleeding remains a common reason for hospitalization in the United States. The main objective of this study was to analyze demographic variations and outcomes in hospitalizations related to esophageal varices (EV) in the US.Methods: We performed a retrospective observational cohort study using National Inpatient Sample (NIS) database for all hospitalizations with discharge diagnoses of EV, with and without hemorrhage from 2001 to 2011.Results: In 2001, there were 19,167 hospitalizations with discharge diagnoses of EV with and without bleeding compared to 45,578 in 2011 (P<0.001). There was a 138% increase in the number of total EV hospitalizations, a 221% increase in hospitalizations with EV without hemorrhage, and a 7% increase in hospitalizations for patients with EV and hemorrhage. Age group 50-64 was the most affected, accounting for 31.4% of EV hospitalizations in 2001 and 46.7% of EV hospitalizations in 2011 (P<0.001). The overall in-hospital mortality rate was 3.4% for patients with EV without hemorrhage and 8.7% for patients with EV with hemorrhage (P=0.0003). Conclusions:The number of hospitalizations for patients with asymptomatic EV increased significantly between 2001 to 2011, with only a small concurrent increase in the number of hospitalizations for patients with esophageal variceal bleeding.

show abstract

“…Врло честа неуспешна контрола крварења као и рано поновно крварење чине ову терапију изузетно скупом у поређењу са трошковима лечења других болести дигестивног система (36). Једна фармакоекономска студија у Француској показала је да просечни трошкови болничког лечења пацијената са акутним вариксним крварењем, који су праћени 46 дана а захтевали су само иницијалну терапију заустављања крварења, износе 9.906 евра.…”

Section: фармакоекономске анализе употребе соматостатина и његових анunclassified

“…Једна фармакоекономска студија у Француској показала је да просечни трошкови болничког лечења пацијената са акутним вариксним крварењем, који су праћени 46 дана а захтевали су само иницијалну терапију заустављања крварења, износе 9.906 евра. Просечни трошкови лечења пацијената код којих иницијални третман није дао успеха износе 23.113 евра и 29.406 евра за пацијенте којима су потребне једна или две додатне процедуре за успостављање контроле крварења (36).…”

Section: фармакоекономске анализе употребе соматостатина и његових анunclassified

The use of somatostatin and octreotide in the treatment of gastrointestinal bleeding

Mijailović¹

2013

Medicinski casopis

View full text Add to dashboard Cite

УВОДКрварења из гастроинтестиналног тракта представљају изузетно озбиљна и ургентна стања у клиничкој пракси. Узроци крварења су врло различити, а из дидактичких разлога ова крварења подељена су на крварења из горњих и доњих делова гастроинтестиналног тракта. Акутна крварења из горњих делова гастроинтестиналног тракта (делови од усне дупље до Treitz-oвог лигамента) најчешћа су ургентна стања у гастроентерологији, сa морталитетом од 6-14%. Стопа инциденце показује широку географску варијацију у опсегу од 48 до 160 случајева на 100.000 становника, са већом инциденцом међу особама мушког пола и старијим особама (1).Узроци ових крварења су пептички улкуси (31%-67%), ерозије, езофагитиси, тумори, малигнитети, Маllоry-Weiss синдром и нешто ређе (2-8%) ретка стања као што су ангиодисплазије, хемобилија, вазоентеричне фистуле, гастричне антралне васкуларне лезије, Dieulafoy лезије (1). Посебан узрок акутних крварења из горњих делова гастроинтестиналог тракта представљају вариксна

show abstract

Cost of treatment of oesophageal variceal bleeding in patients with cirrhosis in France: results of a French survey

Cited by 17 publications

References 21 publications

Non-invasive diagnostic assessment tools for the detection of liver fibrosis in patients with suspected alcohol-related liver disease: a systematic review and economic evaluation

Non-invasive diagnostic assessment tools for the detection of liver fibrosis in patients with suspected alcohol-related liver disease: a systematic review and economic evaluation

Inpatient burden of esophageal varices in the United States: analysis of trends in demographics, cost of care, and outcomes

The use of somatostatin and octreotide in the treatment of gastrointestinal bleeding

Contact Info

Product

Resources

About